[News Brief] Takeda and Indonesian Government Partner to Advance Plasma Healthcare
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to…
Global PR
[News Brief] Bristol Myers Squibb Names Singapore as Pan Asia Hub
Bristol Myers Squibb (BMS) has recognised Singapore as its new Pan Asia Cluster (PAC) hub, supported by the Singapore Economic…
[News Brief] UCL and Eisai Extend Neurodegenerative Disease Research Partnership
University College London (UCL) and Eisai Co., Ltd. have signed a new agreement extending their collaboration in drug discovery and…
[News Brief] Cadila Pharmaceuticals and Wellesta Holdings Sign Joint Venture MoU
Cadila Pharmaceuticals and Wellesta Holdings have signed a memorandum of understanding to establish a strategic joint venture focused on commercialising…
[News Brief] China NMPA Standardises Medical Device Reclassification Procedures
China’s National Medical Products Administration (NMPA) has issued Announcement No. 52/2026, establishing a procedural framework to standardise the management of…
[News Brief] Abbisko Expands R&D Collaboration with Eli Lilly
Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with Eli Lilly and Company to discover and…
[News Brief] Haisco Licenses Drug Candidates to Nuvectis
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with US-based biotechnology company Nuvectis for two internally developed clinical-stage…
[News Brief] CeleCor Completes FDA Application for Heart Attack Drug
CeleCor Therapeutics has completed its New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for investigational…
[News Brief] IHLD MedTech Secures Strategic Investment from UltraGreen.ai
IHLD MedTech has secured an initial investment commitment from Singapore-listed healthcare technology firm UltraGreen.ai to support the growth of its…
[News Brief] AnHorn Medicines Secures Regulatory Clearances for AH-008
AnHorn Medicines has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration and Index Case designation…